Licea-Martínez JC

Language: Spanish
References: 9
Page: 232-234
PDF size: 213.62 Kb.

Text Extraction

No abstract

REFERENCES

1. Blanchet B, et al. Influence of burns on pharmacokinetics and pharmacodynamics of drugs used in the care of burn patients. Clin Pharmacokinetics. 2008;47:635-654.

2. Ansermino M, Hemsley C. ABC of burns intensive care management and control of infection. BMJ. 2004;329:220-223.

3. Sheridan RL, Weber JM. Mechanical and infectious complications of central venous cannulation in children: lessons learned from a 10-year experience placing more than 1,000 catheters. J Burn Care Res. 2006;27:713-718.

4. Jan YH, et al. Central venous catheter-related infection in major burn patients: comparison of subclavian vein and femoral vein. Korean Journal of Critical Care Medicine. 2011;26:245.

5. Latenser BA. Critical care of the burn patient: the first 48 hours. Crit Care Med.2009;37:2819-2826.

6. Woodson LC, Sherwood ER. Anesthesia for burned patients. In: Herndon DN. Total burn care. 2007: 196-223.

7. De Gasperi A, et al. Pharmacokinetic profile of the induction dose of propofol in patients with severe burns. Clin Drug Invn.1997;14:314-320.

8. Cancio LC, Cuenca PB, Walker SC. Total intravenous anesthesia for major burn surgery. Int J Burn Trauma. 2013;3:108-114.

9. Yamashita S, Kaneda K, Han TH. Population pharmacokinetics of a propofol bolus administered in patients with major burns. Burns.2010;36:1215-1221.